In a mouse model of AD, in which mutant human APP and mutant human presenilin‐1 (PS1) are expressed, treatment with minocycline improved the performance of hippocampal‐dependent learning tasks and increased survival of abGCs but did not restore dendritic shrinkage and spine loss (Biscaro et al., 2012). This evidence concerns the gene APP and Alzheimer disease.